The company has scheduled Analyst/Investor Meetings as part of investor outreach activities.
The event type includes 1x1 Meetings and Group Meetings.
Date and Time Details:
November 4th, 2026 at 09:00 A.M. BST Onwards in London
November 5th & 6th, 2026 at 09:00 A.M. GST Onwards in United Arab Emirates (UAE)
The stated purpose is to meet with investors/analysts, with discussions based exclusively on publicly available information.
The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during these meetings.
Management participants are referred to as "Officials of the Company" but no specific names or designations are provided in this disclosure.
No indication is provided about making presentations, earnings decks, transcripts, or recordings available.
Additional Notes Section
This is a regulatory disclosure made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The intimation is also available on the company's website at www.coronaremedies.com.
The document notes that changes to the schedule may occur due to exigencies on the part of the Host or Company.
No financial data, guidance references, or presentation summaries were included in this announcement.
